Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Quantumzyme (QTZM) EBITDA Margin (2016 - 2018)

Quantumzyme (QTZM) has 4 years of EBITDA Margin data on record, last reported at 6.21% in Q2 2018.

  • For Q2 2018, EBITDA Margin rose 17651.0% year-over-year to 6.21%; the TTM value through Oct 2024 reached 218.76%, changed N/A, while the annual FY2018 figure was 13.81%, 1636.0% up from the prior year.
  • EBITDA Margin reached 6.21% in Q2 2018 per QTZM's latest filing, up from 3.69% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 6.21% in Q2 2018 and bottomed at 276.55% in Q1 2017.
  • Average EBITDA Margin over 4 years is 49.71%, with a median of 5.52% recorded in 2016.
  • Peak YoY movement for EBITDA Margin: plummeted -27103bps in 2017, then skyrocketed 28024bps in 2018.
  • A 4-year view of EBITDA Margin shows it stood at 7.23% in 2015, then crashed by -1151bps to 90.47% in 2016, then skyrocketed by 91bps to 8.05% in 2017, then skyrocketed by 177bps to 6.21% in 2018.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 6.21% in Q2 2018, 3.69% in Q1 2018, and 8.05% in Q4 2017.